8-KLeadership Changes

QUEST DIAGNOSTICS INC 8-K Report, Executive Changes (Feb 23, 2011)

Filed February 23, 2011For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on February 23, 2011, to report a change in its Board of Directors. Rosanne Haggerty has decided not to seek re-election to the Board at the upcoming Annual Meeting of Stockholders on May 17, 2011. Ms. Haggerty will retire from the Board after serving for 9 years, with her retirement being effective on the date of the Annual Meeting. This development signifies a transition in the company's board composition. While the departure is framed as a planned retirement, investors should monitor any further announcements regarding board appointments or strategic shifts that may follow this change in leadership. The filing itself does not provide details on the reasons for Ms. Haggerty's decision or any immediate implications for the company's operations or financial performance.

Key Highlights

  • 1Rosanne Haggerty, a Director on Quest Diagnostics' Board, will retire.
  • 2Ms. Haggerty will not seek re-election at the May 17, 2011 Annual Meeting of Stockholders.
  • 3Her retirement is effective as of the date of the Annual Meeting.
  • 4Ms. Haggerty has served on the Board for 9 years.
  • 5The event is classified under Item 5.02(b) of Form 8-K, pertaining to director departures.
  • 6The earliest event reported is February 16, 2011.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report the decision of Director Rosanne Haggerty not to seek re-election and her subsequent retirement from the Quest Diagnostics Board of Directors.

Ms. Haggerty's retirement from the Board will be effective on May 17, 2011, which is the date of Quest Diagnostics' Annual Meeting of Stockholders.

The filing states that Ms. Haggerty has decided not to seek re-election and will retire after 9 years of service. There is no information provided in this 8-K to suggest any underlying issues or immediate strategic changes; it is presented as a planned retirement.

Rosanne Haggerty has served on the Quest Diagnostics Board of Directors for 9 years.